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Dynamic changes of naïve T cells determine mature T cells activity in cell-mediated immune response. It is important to 
understand the mechanism of homeostasis maintenance affect response to novel antigen toward T cell receptor-major 
histocompatibility complex interaction. Most of the analysis of naïve T cells relies on flow cytometric immunophenotyping 
to observe surface antigen alteration within maturation stage. The combination of different surface molecules, such as 
the cluster of differentiation 62L (CD62L), C-C chemokine receptor type 7 (CCR7), CD27, CD28, and CD45, can give satisfied 
discrimination between naïve T cells and other subsets. This parameter can be used to monitor the dynamic change of naïve 
T cells in some chronic diseases, like human immunodeficiency virus (HIV) and cytomegalovirus (CMV). Most of the patient 
experience loss of naive T cells due to a chronic immune response, which related to apoptotic induction in proliferating cells 
by viral activity. Some pathogens trigger the migration of naive T cells into lymph nodes to facilitate direct contact with the 
host cells. The virus infects the cells, use cells proliferation to multiply, and induce apoptosis of host cells after the virions 
released. Alteration of naive T cells in chronic disease becomes a parameter to oversee the treatment and to determine 
the future prognosis of the disease. In highly active antiretroviral therapy for HIV infection, observation of naïve T cells and 
combination of surface molecules, CD45RO− and CD27+ is used to show the improvement and proliferation rate of total 
naïve T cells. On the other hand, the transformation of naïve T cells into CMV-specific T cells become really important in 
CMV prognosis. These conditions suggest that dynamic change of naïve T cells affect to the clinical condition of chronic 
disease patients. 
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Introduction
An adult human is able to produce more than one million 
blood cells every second on a homeostatic condition in 
bone marrow. Hematopoietic stem cells (HSCs) develop 
into erythrocytes, platelets, myeloid cells, mast cells, 
leukocytes and dendritic cells (DCs).1,2  The balance of 
the hematopoietic system is carried out with continuous 
regeneration by HSCs to meet the body’s need to replace 
short-lived cells.3 
 Leukocytes are the core of the immune system and 
derived from multipotent HSCs.4 Leukocytes are classified 
C e l l  a n d 
B i o p h a r m a c e u t i c a l 
I n s t i t u t e
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as lymphocytes and myeloid cells.5 Lymphocytes are divided 
into T, B and natural killer (NK) cells, which function in 
cell-mediated immunity. T cells have a big role in adaptive 
immunity, which directly contacts with foreign particles and 
eliminates them by cytotoxic activity, or process cytokine to 
induce activation of particular cells that protect the body.6 
Cytokine is recognized by microparticles as an intracellular 
communication implication in disease.7
 HSCs develop into naïve T cells, which are released 
by thymus in condition with the absence of antigen.8 Naïve 
T cells circulate in the bloodstream and move into different 
lymph nodes to initiate the introduction of antigen. Foreign 
particles carry unique antigen peptides which can be 
recognized by T cells receptor (TCR) with the mediation 
of antigen presenting cells (APCs), such as dendritic cells, 
macrophage, or B cells. APCs bind the peptides with 
major histocompatibility complex (MHC), move toward 
T cells, and create simultaneous signal to trigger the 
activation of T cells.9  Activated T cells will differentiate 
into heterogeneous population depends on the expression of 
homing molecules.10
 Maturation of naïve T cells change them into one of 
the cluster of differentiation 4+ (CD4+)CD8− or CD4−CD8+ 
cells and finally released from thymus to peripheral tissue.8 
Double positive CD4+CD8+ cells that interact well with 
MHC class I will mature into CD8+ cells, whereas the ones 
interact with MHC class II molecules become CD4+ cells. 
Cytokines are crucial in the differentiation of T cells lineages 
by influencing the transcription factors and epigenetic of the 
cells.4 
 T cells are divided into effector cell (TEF) and memory 
cell (TM). TEF is a wide group of active T cells that include 
helper (TH),  cytotoxic (TC) and regulatory T (TREG) cells. 
TH cells assist other leukocytes in the immunologic process. 
TH helps the maturation of B cells and the activation of 
macrophage and TC cells. TH cell expresses CD4 which 
directly contact with MHC class II on the surface of APC and 
release cytokines.4,8 Furthermore, TC cell will recognize the 
target cell through the interaction of CD8 receptor and MHC 
class I molecule. TC cell releases perforin and interferon 
(IFN)-γ to induce apoptosis of the target cell.11 At the end of 
immune response, TREG cell will produce interleukin (IL)-
10, adenosine and other signaling molecules to inactivate 
TC cell in preventing autoimmune diseases. Survived T cell 
serves as TM cell to response the same antigen for the second 
infection. They rapidly expand to TEF cell upon re-exposure 
to cognate antigen.8
T Cells Homeostasis: Mechanism of T Cells 
Maturation
A Most mature naïve T cells are maintained without 
proliferating and remain fairly constant in the periphery. 
These mature T cells pool is regulated by complex 
homeostasis mechanism. Homeostasis needs to preserve as a 
way to ensuring balanced loss and replacement of peripheral 
naïve T cells. Naïve T cells pool maintain the diversity 
of unique antigen receptors in limited space by extrinsic 
survival cues. MHC complex is crucial to maintaining the 
homeostasis of naïve T cells pool, which the expression of 
MHC molecule is necessary for the preservation of double 
phenotype naïve T cell into mature CD8+ or CD4+ T cell.6,8 
These stimuli give potential changes in characteristics which 
vary depending on TCR intensity and competition between 
naïve T cells in the thymus. However, the competition in 
naïve T cells pool is still unclear since specificity of each 
cell is affected by various factors.
  A distinct pattern of T cells competition has been 
reported as potential mechanism to sustain T cells diversity. 
Some studies suggest that T cells with the same specificity 
compete for each other towards same self-peptide-MHC 
complexes, when other T cells are unaffected (Figure 
1a).12 This model has limited access to self-peptide-MHC 
complexes in order to control the size of the T cells pool and 
restrict the effect of intraclonal competition. It is proven by 
the transfer of low frequency of monoclonal, TCR-transgenic 
CD4+ resulted in longer survival for the T cell than seeded in 
higher frequency in a normal environment.13 This led to an 
improvement in CD4+ T cells pool donor which suggest that 
homeostasis of the naïve T cell pool produces an optimal 
number of T cells with the same specificity.14 
 In contrast, other studies suggest the competition 
within different specificities. TCR diversity allowed each 
of T cell to compete for various non-specific self-peptide-
MHC ligands. TCR of one population could interact with 
self-peptide-MHC complexes that support the different 
T cells specificity (Figure 1b).15,16 Competition between 
different specificity of T cells allows a domination of one 
clone over another to react with self-peptide-MHC in the 
present of external supports, such as survival factors (Figure 
1c).16 In this case, TCR engagements within the cells are not 
equivalent. Stronger naïve T cells are more effectively to 
compete and leave weak cells to die by apoptosis.
 Some previous studies found an interesting fact that 
CD5 correlate with the regulation of competition hierarchy 
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of TCR. CD5 is a negative regulator of lymphocyte receptor 
signaling. CD5 expression was found higher in stronger 
TCR signaling intensity and showed superior homeostatic 
properties than any other cells. CD5hi naïve T cells proved 
that stronger sensitivity of TCR gives the best survive chance 
in selection mechanism by self-peptide-MHC complexes.17 
The  dominance  of  superior  naïve  T  cell  is  affected 
by limiting factors (e.g., intraclonal competition) to prevent 
complete domination even the cells have competitive 
advantage. These models may lack in some interpretations 
since most of the studies occur in lymphopenic condition 
that radically altered T cells homeostasis. However, they 
provide a fascinating explanation of how MHC specificity 
may  affect  competitive  survival  of  naïve  T  cells  in 
polyclonal pool.
 Based on several previous studies, the effect of self-
peptide-MHC complexes on sensitivity to foreign antigen 
is still arguable. One study showed positive correlation 
between naïve CD4+ T cells with self-peptide-MHC 
complexes. In this study, in vivo naïve CD4+ T cells which 
lack MHC class II molecules showed low proliferation 
rate and IL-2 production in in vitro simulation of antigen-
MHC class II.18 This emphasizes how self-peptide-MHC 
complexes capable of supporting naïve T cells sensitivity 
towards antigenic stimulation. In another hand, other 
studies have reported that loss of self-peptide-MHC class 
II complexes enhanced early activation of CD4+ T cells. 
MHC-TCR binding elevates CD5 expression in CD4 naïve 
T cell and increases the strength of MHC interaction. 
However, this interaction triggers a reduction in response 
to TCR signaling.19 This shows the correlation between the 
regulation of CD5 expression and TCR response in order to 
induce the activation of naïve T cell activation.
 In CD8 T cells, activation and expression of the cells are 
controlled by self-peptide-MHC class I complexes in order 
to discriminate antigen specificity. In MHC class I deficient 
mice, transferred CD8+ T cells just showed responsiveness 
to weak foreign peptide due to in vivo response to DCs even 
in lack of MHC class I molecule.20 Following this condition, 
CD8+ cells showed normal proliferation rate and an 
improvement in IFN-γ production to secondary stimulation, 
while continuous contact with self-peptide-MHC complexes 
triggers activation threshold.21 This concept might serve as 
prevention to auto-reactive T cells.
Figure 1. Naïve T cells competition. Model of 
naïve T cells competition towards self-peptide-MHC 
complexes. a) Interclonal competition of the same 
specificity in the same pool. In this model, each 
group of naïve T cells maintenance of these two pools 
independently. b) Mixed TCR of one population 
allows them to compete in different self-peptide-
MHC complexes, limiting the T cell space for other 
specificities. c) This model is allowing T cells of one 
specificity to more effectively compete for a limited 
survival factor (such as cytokine) when interacting to 
its unique self-peptide-MHC complexes.
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 Naïve CD4 T cell response is also related to T cell’s 
motility. CD4+ T cells have to move properly in lymph 
nodes to detect the existence of DCs. Declining of Ras-
proximate-1 (RAP1) and Ras-related C3 botulinum toxin 
substrate 1 (RAC1), which act as guanosine triphosphatase 
to regulate actin cytoskeleton and adhesion molecules 
in lymphocyte movement, give great impact to cells 
motility.22 These models show a promising mechanism 
to understand how TCR sensitivity affect naïve T cells to 
react to the presence of foreign antigen in lymph nodes. It 
raises an issue to determine the effect of self-peptide-MHC 
complexes with various physiological in vivo properties for 
clear interpretation.
Naïve T cells Immunophenotyping
Activated naïve T cells differentiate into TEF subsets and 
TM subsets. Unfortunately, the alteration of T cells within 
the immune response doesn’t indicate any mutation in the 
receptor genes and cell structure; however, the changes 
only occur in cells phenotype. It’s hard to differentiate 
those cells in gene-based analysis and morphologically, 
but not in cytometry analysis. Flow cytometry is an 
accurate instrument to distinguish specific cell within a 
population based on surface antigen expression, including 
T lymphocytes subsets.  
 Naïve T cells express CD62L and C-C chemokine 
receptor type 7 (CCR7)/CD197, which are useful 
parameters to discriminate naive T cell with TM cell. 
CD62L and CCR7 are adhesion molecules that involved in 
naïve T cells migration through the lymph nodes via high 
endothelial venules (HEV). CD62L and CCR7 respectively 
bind to surface vascular addressin and chemokines on the 
surface of HEV in peripheral blood.23 In contrast to the 
naïve T cells, these molecules are expressed differently 
in TM subsets, CD62L+CCR7+ express on central memory 
(TCM) cell and CD62L−CCR7− on effector memory (TEM) 
cell.24  TEM cell lacks CD62L and CCR7 because the cell’s 
migration doesn’t pass the HEV, but circulate through the 
network of extra-lymphoid tissue. In the expansion of T 
cells, these memory cells will express perforin and IFN-γ 
in high concentration in the second response, indicates the 
cells already differentiated into activated TEF.11
 Other surface molecules that used to distinguish naïve 
T cells and TM are CD44, Ly6C, CD122 (IL-2 β-chain) 
and CD45 (common leukocyte antigen).9,25 Naïve T cells 
do not express CD44, Ly6C and CD122, but they slowly 
expressed later in the initiate phase of TM cells formation. 
TM strongly expresses these three molecules, both on TCM 
and TEM subsets. Ly6C weakly expressed on TEF, so that 
these parameters can be used to distinguish TM CD8+ 
with TEF.25 CD45 is a tyrosine phosphatase which has role 
in regulating signaling molecules through antigen and 
chemokine receptors.9 CD45 used to discriminate naïve T 
cells to TM based on the existence of splicing regions of each 
isoform. High molecular weight CD45 isoform or CD45RA 
is expressed on the cell with low division rate and low 
response to the antigen. At the activated state, these cells 
lost CD45RA molecules and replaced with low molecular 
weight isoform, CD45RO, which has no exons (A, B, C 
exon). The population of CD45RO tends to divide rapidly 
and more responsive to the antigen.11
 CD27 and CD28 are effectively discriminate between 
naïve and TEF CD8+. CD28 and CD27 serve as co-stimulator 
in the cell adhesion and signaling molecules between APC 
and TCR.25 These molecules expression will slowly down-
regulated after TCR stimulation or on late differentiated 
cells.26,27 Studies in mice showed that cell which lack of 
CD27 and CD28 has great potential to produce perforin 
and granzyme to induce apoptosis in infected cells.28 In the 
human cytomegalovirus (HCMV) carrier, clone of T cells 
which distributed into two subpopulations, CD27+ CD28− 
CD11ahi and CD27− CD28− CD11ahi, showed high cytotoxic 
activity that indicates the potential of TEF. Upregulation of 
CD11a also occurs on TCM, but not in naïve T cells, which 
have CD11alo.29
Alteration of Naïve T Cells in HIV & CMV 
The body will expose to a lot of antigens that decrease 
the quantity and quality of immune cells as a result of the 
increasing proportion of antigen-experienced cells.30 The 
morbidity and mortality of the disease will increase in 
the elders coincide with involution of immune organs or 
immunosuppression agents. Immunosuppression is a state 
when the immune system is reduced in certain conditions 
by external factors, e.g., rejection after donor transplant, 
chemical therapy or mostly due to bacterial/viral infection. 
Immunosuppression is a serious condition which makes 
the immune system can’t act as normal host defense 
system, which called immunologic deficiency. There are 
two common categorize of immune deficiency: primary 
immunodeficiencies (PI) and secondary immunodeficiencies 
(SI).31 PI are manifest early in life as repeated infections in 
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normal children. In the chronic state, PI can be a serious 
disease which affects a single or multiple parts of the 
immune system. These diseases are caused by hereditary or 
genetic defect which results in immune abnormalities and 
infection susceptibility.32 In the other hand, SI arises outside 
of the immune system and not restricted only to immune 
elements (multisystem biochemical defect and nutritional 
deficiency that have possibility to depress immune system 
are included). SI commonly occurs in older age group, 
characterized by excessive loss of lymphocytes.31
 Dysregulation of various lymphocyte precursor cells 
causes disruption of population, function and homeostasis 
condition of the immune system, especially on T cells 
and B cells.33 Viral and bacterial exotoxins can induce 
over-exploitation of lymphocytes. Approximately 20% 
of lymphocytes are stimulated by exotoxins which lead 
to chronic inflammation and fatal condition, like sepsis.34 
Damage of T cells is also correlated to age-related effects 
in immune system. Transfer of young T cells in old mice 
showed improvement in antibody production, compared 
with non-treatment old mice. In contrast, young mice which 
had received old T cells exhibited a reduction in B cells 
response and antibody production. This is presumably due 
to the decreased expression of CD40 ligand associated with 
APC that affect in mediated immune system.35
 As explained previously, exposure to foreign antigens 
continuously can reduce the number of naïve T cells 
among total T cells. The rate of naïve T cells alteration is 
different in each individual, connected to several factors, 
such as genetics, nutrition or environmental conditions 
which support the spread of infectious diseases. Individuals 
in certain population will show lymphocyte phenotype 
differently from other populations. The comparative study 
on non-human immunodeficiency virus (HIV) Dutch 
and Ethiopia population found significant differences in 
lymphocyte number. Ethiopian population tends to have 
fewer in the total of naïve T cell, but higher in memory 
and effector cells.36 In another study, comparative of 
naïve T cells number between Malawi and UK population 
showed distinction pattern, both in respondents with CMV 
seropositive & seronegative. CMV seropositive in UK 
population showed a higher number of naïve T cells even 
compared with healthy Malawian.37 This phenomenon 
occurs due to the high risk of infectious diseases, such as 
malaria, CMV and HIV, faced by the African. The decline in 
naïve T cells associated with the accumulation of memory 
and effector T cells that don’t have a co-stimulatory molecule 
of CD28. CD28 plays an important role in the ligation 
between T cells to target tissue in the immune response.38
Naïve T cells alteration in HIV patients
Wild-type HIV is a subgroup of retrovirus that causes 
acquired immunodeficiency syndrome (AIDS). People with 
AIDS are threatened by opportunistic infections and cancers 
due to progressive failure of the immune system. According 
to The Joint United Nations Programme on HIV/AIDS 
(UNAIDS), there are more than 45 million people have 
been infected, and over 90% live in developing countries. 
HIV can be transmitted via blood, genital fluid and breast 
milk in free virus particles and infected cells form. HIV 
can infect T lymphocytes (mostly TH cells), dendritic and 
macrophage cells. The viral infection mechanism occurs 
through apoptosis of infected cell, pyroptosis, direct killing 
or using TC cell to kill TH cell. Infected patients able to life 
longer as normal human with intensive treatment, but the 
survival rate drops to 9-11 years on the untreated patient.39 
 Monitoring the level of T cells in HIV patients can 
be used to study the mechanisms of infection and T cell 
depletion in a comprehensive manner. Alteration in T cells 
during the infection phase can be measured using the T 
cell receptor excision circles (TRECs) which represent the 
function of the thymus organ.40,41 Reduction the number of 
naïve T cell on HIV patients due to hyperactivation of the 
immune system, lead to increasing the number of memory 
cells that lack to response with new antigens.42 HIV type-1 
enhances the priming of naïve T cell by inducing chronic 
immune activation and boost up the proliferation rate. At the 
same time, the decline in naïve T cells by HIV type-1 will 
be applicable as a homeostatic mechanism that aims to keep 
the number of naïve T cells remains constant at the current 
rate when proliferation phase continue revolving.43
 The death rate of T cells also detected during HIV 
type-1 infection.44 On steady-state conditions, virus in 
the lymphoid tissues might provide signals resembling 
lymphocyte homing and circulation mechanism. This signal 
is up-regulating the homing receptor of CD62L that triggers 
naïve and central memory T cells to migrate toward the 
lymphoid tissue. Regulation of CD62L was also supported 
by signal molecules from the abortive cell, an unstable cell 
that carries certain virus which unable to enter the host cell 
nucleus. Through CD62L, virions or virus-producing cells 
may provide signals to target cells that trigger apoptosis.45,47 
Infected cells can last for two days before death to produce 
more viral progeny.46 Meanwhile, proviral can last several 
months or years and usually found in latent infection.47 
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Latent infection is suspected to be correlated with the 
presence of naïve T cells because the longevity of naïve 
T cells and the ability of naïve T cells to proliferate & 
differentiate to another cell to help viral multiplying. Naïve 
T cell differentiation makes biased detection of latent 
infection source that was allegedly formed from central 
memory T cells or effector memory transition T cells.48
Naïve T cells alteration in CMV infection
CMV is a herpes virus with a world seroprevalence ranging 
from 45-100%. In immunocompromised patient, viral 
acquisition occurs via reactivation of latent infection or 
primary infection. Congenital CMV affects 0.6-0.7% of live 
births in industrialized countries with 10% of the population 
show symptomatic disease, such as microcephaly or 
deafness, and 4% die during the newborn period. Hereafter, 
primary CMV is the most common infection after organ 
transplantation. Patient with CMV shows several clinical 
syndromes, e.g., encephalitis, pneumonitis, hepatitis, uveitis, 
retinitis and colitis. In healthy adults, the viral particles 
become latent, self-limiting into lifelong bloodborne virus.49
 CMV infection is known to cause end-stage 
differentiation and replicative senescence of T lymphocytes 
and lead to increasing risk of infectious diseases, 
degenerative conditions and neoplasm abnormality.50 
Patients with CMV seropositive have lower percentage of 
naïve T cells, but showed an escalation in the proportion 
of CD28− CD45RO+ memory cells.37 CMV seropositivity 
was associated with oligoclonal expansion in differentiated 
CD28− CD57+ T cells. The appearance of these cells indicates 
the reduction of naïve and memory T cell response against 
other antigens.51 Some cases in adults (aged 19-55 years), 
patient with CMV seropositive showed 10% of T cells with 
CMV-specific phenotype within overall number of CD4 and 
CD8 T cells52 as the mechanisms from the virus to suppress 
the diversity and function of T cells. Latent infection can 
show no symptoms in immunocompetent person, but with 
substantial change, it can be dangerous for patients with 
immunocompromised conditions. This is associated with 
"immune risk people" (IRP) which inducing high risk of 
mortality due to fragile immune response.
 IRP does not always portend to poor prognosis, 
but with aging, CMV progressively creates higher viral 
replication. Antigen stimulation will gradually improve the 
number of CMV specifics T cell, trigger cell dysfunction 
due to excessive activity of non-senescence T cells, and then 
replace the functional T cells with new poor generation. 
Viral replication will suppress the population of naïve 
and memory T cells by creating a chronic inflammatory 
condition, lead to disrupting T cells homeostasis.53 This 
condition in will be maintained by the virus at the same 
level as chronic immune suppression of viral infection, 
such as HIV.52 On immunocompetent patient, relapse of 
CMV infection is suggested by the existence of CMV-
specific memory T cells. Basically, CMV-specific T cells 
functionally working to response CMV activity and keep 
them in resting state. In many cases of CMV, there was no 
obvious symptom to specific disease, although CMV has a 
high reactivity after immunosuppressive therapy.54
 CMV pathogenicity may be affected by intrinsic 
senescence mechanisms of CMV-specific T cells. CMV-
specific T cells have shorter telomeres character and high 
mutation rate to make these cells life is very short. One of the 
possibilities why the frequency of CMV relapse is increasing. 
CMV-specific T cell populations replace the naïve cell and 
memory cell pools that interfere T cells homeostasis. At 
some points, when body reach a lower condition of immune 
system, it will be an opportunity for CMV to out from resting 
state and boost their replication. CMV replication followed 
by other infectious complications may increase mortality of 
patients.54 On the other hand, there is a counter-argument 
of the role of CMV-specific T cells in immune suppression. 
CMV-specific T cells are just a few of the total T cells found 
in lymph nodes that are not capable of replacing the naïve 
and memory T cell pools. Replicative senescence and some 
'abnormal' conditions can also be found in the pattern of 
differentiation of effector memory cells in all ages, younger 
or older.55 For the alternative scenario, replication of CMV 
and CMV-specific response in each individual are initiated 
by age-related diseases.54
Determining Prognosis of Highly Active 
Antiretroviral Therapy (HAART) 
HAART is a new breakthrough in the restoration of CD4 
T cells in HIV infection. Immunophenotyping of naïve T 
cells  is  useful  in  the  post-therapy  monitoring  while 
learning about HIV pathogenicity. This treatment proved 
capable of reducing viral load, expand the survival rate, 
and less painful than any other treatment. Unfortunately, the 
limit of availability and the high cost of the medicine are 
the main consideration to the implementation of HAART 
in some countries. In addition, resistance to viral drug and 
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ineffective  outcome  of  HAART  had  been  found  in 
certain patients.56,57
 In the first study, patients will receive a combination of 
drugs at the initiation of therapy, such as indinavir, nevirapine, 
lamivudine, zidovudine, and/or stavudine. Within a certain 
time during the duration of therapy, respondent will go 
through a series of test to observe naïve T cells (CD45RO− 
and CD27+), memory T cells (CD45RO+ and CD27−), 
effector T cells CD4 (CD45RO+ and CD27−), and effector 
T cells CD8 (CD45RO+/− and CD27−). Proliferation level of 
CD4 and CD8 was analyzed by Ki67 staining and dynamic 
change on T cells with CD4+ CD45RO− dan CD8+ CD45RO− 
was measured with 5-bromo-2'-deoxyuridine (BrdU). The 
results showed significant increase in the number of naïve 
T cells CD4 and CD8 with a reduction of cell proliferation 
level by Ki67 staining. Kinetic change on naïve T cells with 
BrdU showed lower level of cell proliferation and apoptosis 
rate after six months treatment with HAART.41
 A decrease in the proliferation level which proportional 
with cell death rate explained that priming T cells into 
memory T cells are related with reduction of naïve T cells 
in HIV infection. Normalization of T cells also associated 
with the increase in the population of naïve CD4 and CD8 
T cells, although the CD4 T cells showed better outcome 
than CD8 T cells. This is indicating the independent 
mechanism between CD4 and CD8 T cells. With this model 
study, TRECs outcome showed similar mechanism in the 
priming stage of naïve T cells into memory cells in both 
populations, but the naïve CD4 T cells exhibited higher 
cell death rates than CD8 T cells. This discovery supports 
earlier theory about the preference of HIV type-1 infection 
to interfere naïve CD4 T cells.58 Observations on ligand-
mediated apoptosis in the acute immunodeficiency simian 
virus (SIV) indicate large amounts of virions exposure in 
the CD4+ T lymphocytes, but not in CD8+.59 A theory that 
maybe supports this outcome is the nature of the CD4 T 
cells which has higher levels of proliferation rate than CD8 
T cells.41
 As mentioned earlier, in some cases, HAART treatment 
did not show significant progress towards CD4 population, 
although the treatment showed a promising result to suppress 
the viral replication.57 Damage to the reticular fibroblastic 
cell (FRC) is one of the possible reasons to reduce T cells 
restoration during the treatment with HAART. FRC serves 
as migration pathway for naïve T cells to access various 
survival factors, such as Interleukin-7 (IL-7). Damaged FRC 
increase cell apoptosis rate and decrease the recovery of T 
cells after treatment with HAART.60 Animal models with 
SIV with suffered lymphoid tissue as a result of collagen 
disposition showed increased in cell apoptosis of naïve CD4 
and CD8 T cells. This is associated with an incapability 
naïve T cells to access IL-7.61 Lymphoid tissue fibrosis is 
progressive and accumulative. Treatment of HAART should 
be applied early as possible when collagen disposition 
and FRC damage still on low level.62 It will increase the 
probability of successful treatment.
 At more advanced stage, accumulation of damage 
in lymphoid tissue with increased collagen deposition and 
disruption of FRC in chronic infection. Reconstruction 
of naïve T cell will be worse in older patients. Involution 
of thymus and degeneration of thymic function limit the 
pace and the restoration rate of naïve T cells.63 Therapeutic 
approach to restoring the lymphoid tissues and FRC is 
important to improve effectiveness of HAART. Therapeutic 
use of IL-7 in conjunction with HAART in HIV and SIV 
infection can significantly increase the number of naïve 
CD4 T cells. However, a decrease in CD4 and CD8 naïve 
T cells number occurs after terminate the IL-7 therapy. 
This indicating that the therapeutic effect of IL-7 is just 
temporary.63,64 For further development, the application 
of anti-fibrotic therapy in FRC and lymphoid tissues, like 
pirfenidone and losartan, may be used as lymphoid tissue 
reconstruction.62,63
Maintain CMV Infection
CMV infection is benign in immunocompetent patient 
and has to maintain with specific T cell response control 
in order to keep the virus in the latent phase. With aging, 
immune senescence occurs correlated with persistent of 
CMV infection.  CMV infection will induce the production 
of CMV-specific T cells as a response of immune system to 
maintain viral infection. CMV-specific T cells characterize 
by effector memory phenotype (CD28−, CD27−, CCR7−), 
reduce CD4/CD8 ratio and loss in naive T cell number.54 In 
immunocompromised people, this condition causes a higher 
chance of opportunistic infection, such as enteritis and 
pneumonia. Accordance with those conditions, obviously, 
CMV-specific T cell is culpable in the development of 
immune senescence.65 
  CMV-specific T cell may change the immune system 
composition, but its response still needed to maintain 
viral replication. Unfortunately, CMV-specific T cell 
response deteriorates in IRP, allowing more frequent of 
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viral replication. In some previous studies, there are some 
explanations how CMV-specific T cell has roles in maintain 
CMV infection. CMV-specific T cells are widely used 
to prevent of viral infection after hematopoietic stem cell 
transplantation.65,66 CMV-specific cells can be developed 
from naïve T cells from umbilical cord blood (UCB) or 
donors with CMV seronegative. Based on the principle of 
multi virus-specific T cells, naïve donor T cells will create 
the CMV-specific T cell lines from UCB. Isolation of naïve 
T cells is performed by eliminating the memory cells and the 
presence of other viral antigens to increase the specificity 
of the CMVpp65. CMVpp65 a typical epitope commonly 
detected in human leukocyte antigen (HLA)-A2 positive 
donor.67 Naïve T cells from the donor can also recognize 
atypical (less common) CMVpp65 epitope for improving 
the availability of CMV-specific T cells in patients with high 
risk of CMV. The ability of T cells to recognize atypical 
CMV epitope is suspected as an in vivo defense mechanism 
against CMV.66
 Naïve T cells have the ability to recognize the epitope 
more than the memory cell. The specific cell will recognize 
the particular peptide which the expression will vary depend 
on certain stage. The population will be different at each 
stage, from initiation to chronic phase.66,68 T cells response 
is difficult to detect because of the mixed response against 
CMV. This change was also influenced by the dynamic 
change of T cells which be replaced by other T cells over 
time. Identification of the optimal population of T cells to 
the donor becomes important in adoptive immunotherapy.69 
Although this therapy is considerably safe and showed low 
level of viral reactivity after therapy, it’s hard to implement 
this therapy due to complicated mechanism and take more 
times to perform cell culture.66
Conclusion 
Naïve T cell is an essential component in the formation 
of T cell subsets that support the body's immune system. 
Immunophenotyping naïve T cells can be used to help 
identify naïve T cells among T cells subsets, such as 
memory and effector T cells. In the HIV and CMV infection, 
measurement of naïve T cells may help in understanding the 
mechanism of infection more comprehensive. The lower 
level of naïve T cell within the infection period is caused 
by an increasing of cells apoptosis. Either because of their 
excessive proliferation or activation of the cell death signal 
by HIV and CMV viral components. Monitoring naïve T 
cells population during HAART HIV patients showed 
the effectiveness of therapies based on the alteration of 
naïve CD4 and CD8 T cells number. In CMV infection, 
differentiate naïve T cells into CMV-specific T cells triggers 
an imbalance of T cell population which lead to increase 
the vulnerability of other diseases at the same time with the 
decline of immunity. On the other hand, the CMV-specific 
T cells serve to maintain the resting state of CMV in better 
immunocompetent person. With all these explanations, the 
dynamic change of naïve T cells is an important parameter 
in multiple infections associated with immunosuppression.
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